Journal Highlights: Sept.-Oct. 2024November 20, 2024Upper GI TractIBD & Intestinal DisordersLiver DiseaseEndoscopyGI Oncology
Alcohol-Associated Liver Disease and Alcohol Use Disorder on the Rise in Older AdultsNovember 20, 2024Liver Disease
In IBD Patients, No Increased Risk for MACE Seen for JAK Inhibitors vs Anti-TNFNovember 20, 2024IBD & Intestinal Disorders
Alcohol Use Disorder Therapy Remains Underutilized in Alcohol-Associated Liver DiseaseNovember 18, 2024Liver Disease
Endoscopic Sleeve Gastroplasty Yields Durable Weight Loss at 10 YearsNovember 18, 2024EndoscopyUpper GI TractObesity
Reassuring Data on GLP-1 RAs and Pancreatic Cancer RiskNovember 15, 2024Pancreas and Biliary TractGI Oncology
Transitioning from Employment in Academia to Private PracticeNovember 15, 2024Practice ManagementMixed Topics
Does Bezlotoxumab Boost FMT Efficacy in IBD Patients With Recurrent CDI?November 11, 2024IBD & Intestinal Disorders
Angiotensin Receptor Blockers May Lead to Worse Outcomes in Celiac DiseaseNovember 8, 2024Upper GI TractIBD & Intestinal Disorders
